Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
CRXT holding history
Clarus Therapeutics Holdings, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRXT overviewAll 13F holders of CRXTFull Q4 2025 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −1,039,148−100.0% | Sold out | Holders |
| Q2 2022 | 1,039,148 | $397.0K | <0.1% | +864,648+495.5% | Added | Holders |
| Q1 2022 | 174,500 | $260.0K | <0.1% | +7,900+4.7% | Added | Holders |
| Q4 2021 | 166,600 | $405.0K | <0.1% | +166,600 | New | Holders |